ACT

July 10/2018


news roundup

Next Phase Clinical Research Launched

Next Phase Clinical Research has been formed and launched to provide sites and research programs operational guidance.


Advertisement

Debunking the Myths of Risk-Based Monitoring for a New Approach to Quality Management
On Demand
Learn more


Accenture Calls for Emerging Innovators and Disruptors for HealthTech Innovation Challenge

Accenture is currently accepting applications, through September 1, for the third annual Accenture HealthTech Innovation Challenge, which works to improve the way people access and manage healthcare.


Advertisement

Predicting Holistic Clinical Trial Cost Should Not Be A Struggle
Ying Jiang Explains What You Need To Know
On Demand
Learn more


First Hospital, Tbilisi, Joins Clinerion's Global Network of Hospitals

First Hospital, Tbilisi, expands Clinerion's global network of hospitals into Georgia. This partnership allows for Clinerion's clients to gain access to Georgia clinical trial populations. On the other hand, First Hospital will also be able to access to medical interventions for its patients and clinicians.


KCR Expands its Service Portfolio

KCR, a full-service CRO, is extending its service portfolio with Trial Execution Consulting to support clients in translating scientific objectives into operational activity. The new service is dedicated to biotechnology companies as well as small and medium pharma.

Advertisement

FILLING THE GAPS IN SITE SELECTION
What You Don't Know Can Help You
On Demand
Learn more


In this edition

First Hospital, Tbilisi, Joins Clinerion's Global Network of Hospitals
Clinical Design: A Deep Dive
Does the EU Really Care About Health Policy?
Gene Therapy in Rare Disease Research

Advertisement

Driving Product Development and Finding the Fast Track in Early-Phase Oncology Programs
On Demand
Learn more


Events

Direct-to-Patient Clinical Trials
American Pharma Outsourcing Summit
Crossroads: An Artia Solutions Conference
Search Upcoming Events

Advertisement

Is RBM living up to the hype? The state of RBM in clinical development
On Demand
Learn more


Subscribe

Subscribe

Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers »


Articles

Enrollment Cycle Times Can and Should Be Optimized

Case study demonstrates that site activation is a key driver in determining patient enrollment cycle time.


Advertisement

The Future of ECOA
On Demand
Learn more


Clinical Design: A Deep Dive

Findings from a new ACT and SCORR Marketing survey reveal the most actively used flexible design approaches in clinical research—many with application in rare disease.

Blog Posts

Direct-to-Patient Trials: Address Your Audience

CBI Conference Producer, Trevor Sosvielle, recently sat down with Matthew Amsden, CEO of ProofPilot to discuss his early work in HIV prevention trials. Amsden shares how these experiences helped shape ProofPilot and its patient-centric clinical trial approach.


Does the EU Really Care About Health Policy?

How much does the EU really care about health, and about the infrastructure that is a precondition to successful healthcare and healthcare innovation?


Oncology

Gene Therapy in Rare Disease Research

A look at home and dosing site considerations.


 

Hope. The Power for the Rare Disease Journey

Editor-in-Chief Lisa Henderson speak about therapeutic needs, rare diseases in children, and the SCORR Marketing survey on innovative or flexible trial designs.



Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription

Get the full picture


Ask the editor

Lisa Henderson
Editor in Chief
Lisa.Henderson@ubm.com

Advertise

Todd Baker
Group Publisher
todd.baker@ubm.com